PURPOSE: To compare F-18-fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) imaging at two different circulation times after injection of F-18 FDG in order to measure atherosclerosis in carotid arteries. METHODS: We assessed 12 patients with recent symptomatic plaques in the carotid arteries. F-18 FDG PET/CT carotid plaque imaging was performed for 20 min at 2 h after F-18 FDG injection in five patients and at 3 h in seven patients. We measured vessel wall uptake using the maximal standardized uptake value (SUV), and the mean and maximal blood target-to-background ratios (TBR) of the symptomatic carotid arteries. Blood pool activity (BPA) was measured as the mean SUV of the superior vena cava (SVC) and jugular vein of these 12 patients, and in 14 age- and gender-matched patients who underwent whole-body F-18 FDG PET/CT examinations 1 h after injection. RESULTS: F-18 FDG PET/CT revealed visible F-18 FDG uptake in all patients with symptomatic carotid plaques. Maximal SUV did not differ between groups evaluated at 2 h and 3 h (2.62 ± 0.45 vs 3.00 ± 0.85, p = 0.335). However, mean (2.04 ± 0.22 vs 3.54 ± 0.62, p < 0.05) and maximal (1.65 ± 0.15 vs 2.70 ± 0.42, p < 0.05) TBR values that were normalized to BPA in the SVC differ significantly. CONCLUSIONS: Symptomatic carotid plaques are visualized for a relatively short period of imaging time on ≥1-h PET/CT images. Quantitative parameters of atherosclerotic carotid arteries are preserved or even increased over time, whereas those of blood pools are decreased.
PURPOSE: To compare F-18-fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) imaging at two different circulation times after injection of F-18 FDG in order to measure atherosclerosis in carotid arteries. METHODS: We assessed 12 patients with recent symptomatic plaques in the carotid arteries. F-18 FDG PET/CT carotid plaque imaging was performed for 20 min at 2 h after F-18 FDG injection in five patients and at 3 h in seven patients. We measured vessel wall uptake using the maximal standardized uptake value (SUV), and the mean and maximal blood target-to-background ratios (TBR) of the symptomatic carotid arteries. Blood pool activity (BPA) was measured as the mean SUV of the superior vena cava (SVC) and jugular vein of these 12 patients, and in 14 age- and gender-matched patients who underwent whole-body F-18 FDG PET/CT examinations 1 h after injection. RESULTS:F-18 FDG PET/CT revealed visible F-18 FDG uptake in all patients with symptomatic carotid plaques. Maximal SUV did not differ between groups evaluated at 2 h and 3 h (2.62 ± 0.45 vs 3.00 ± 0.85, p = 0.335). However, mean (2.04 ± 0.22 vs 3.54 ± 0.62, p < 0.05) and maximal (1.65 ± 0.15 vs 2.70 ± 0.42, p < 0.05) TBR values that were normalized to BPA in the SVC differ significantly. CONCLUSIONS: Symptomatic carotid plaques are visualized for a relatively short period of imaging time on ≥1-h PET/CT images. Quantitative parameters of atherosclerotic carotid arteries are preserved or even increased over time, whereas those of blood pools are decreased.
Entities:
Keywords:
Atherosclerosis; Carotid arteries; F-18 FDG PET/CT; Imaging time
Authors: Ahmed Tawakol; Raymond Q Migrino; Udo Hoffmann; Suhny Abbara; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman Journal: J Nucl Cardiol Date: 2005 May-Jun Impact factor: 5.952
Authors: Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman Journal: J Am Coll Cardiol Date: 2006-10-17 Impact factor: 24.094
Authors: James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad Journal: J Am Coll Cardiol Date: 2007-08-13 Impact factor: 24.094
Authors: Leon J Menezes; Carl W Kotze; Brian F Hutton; Raymondo Endozo; John C Dickson; Ian Cullum; Syed W Yusuf; Peter J Ell; Ashley M Groves Journal: J Nucl Med Date: 2009-05-14 Impact factor: 10.057
Authors: David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton Journal: Stroke Date: 2008-10-16 Impact factor: 7.914
Authors: J H F Rudd; E A Warburton; T D Fryer; H A Jones; J C Clark; N Antoun; P Johnström; A P Davenport; P J Kirkpatrick; B N Arch; J D Pickard; P L Weissberg Journal: Circulation Date: 2002-06-11 Impact factor: 29.690
Authors: Nicholas R Evans; Jason M Tarkin; Mohammed M Chowdhury; Elizabeth A Warburton; James H F Rudd Journal: Curr Atheroscler Rep Date: 2016-06 Impact factor: 5.113